Home Other Building Blocks 118933-92-9
118933-92-9,MFCD00456074
Catalog No.:AA008U80

118933-92-9 | 1-Methyl-1h-indazol-6-ol

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
95%
in stock  
$49.00   $35.00
- +
250mg
95%
in stock  
$89.00   $63.00
- +
1g
98%
in stock  
$307.00   $215.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA008U80
Chemical Name:
1-Methyl-1h-indazol-6-ol
CAS Number:
118933-92-9
Molecular Formula:
C8H8N2O
Molecular Weight:
148.1619
MDL Number:
MFCD00456074
SMILES:
Oc1ccc2c(c1)n(C)nc2
Properties
Computed Properties
 
Complexity:
151  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
11  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
1  
XLogP3:
1.8  

Downstream Synthesis Route

[1]Patent:US2019/83482,2019,A1.Locationinpatent:Paragraph0286-0287

[2]BioorganicandMedicinalChemistry,2015,vol.23,p.6855-6868

[3]Patent:CN104876912,2017,B.Locationinpatent:Paragraph0047;0228-0231

[4]ChemistryofHeterocyclicCompounds,1988,p.403-409    KhimiyaGeterotsiklicheskikhSoedinenii,1988,vol.24,p.491-498

[5]Patent:WO2014/100730,2014,A1.Locationinpatent:Paragraph00283

118933-92-9   
1-methyl-6-hydroxy-7-nitrosoindazole 

[1]Stankyavichyus,A.P.;Terent'ev,P.B.;Bolotin,V.A.;Lashin,V.V.;Rakhimi,I.M.[ChemistryofHeterocyclicCompounds,1988,p.403-409][KhimiyaGeterotsiklicheskikhSoedinenii,1988,vol.24,#4,p.491-498]

[1]Stankyavichyus,A.P.;Terent'ev,P.B.;Bolotin,V.A.;Lashin,V.V.;Rakhimi,I.M.[ChemistryofHeterocyclicCompounds,1988,p.403-409][KhimiyaGeterotsiklicheskikhSoedinenii,1988,vol.24,#4,p.491-498]

[2]CurrentPatentAssignee:EPIZYME,INC.-WO2014/100730,2014,A1

[3]Dong,Yan;Li,Kehuang;Xu,Zhixiang;Ma,Haikuo;Zheng,Jiyue;Hu,Zhilin;He,Sudan;Wu,Yiyuan;Sun,Zhijian;Luo,Lusong;Li,Jiajun;Zhang,Hongjian;Zhang,Xiaohu[BioorganicandMedicinalChemistry,2015,vol.23,#21,p.6855-6868]

[4]CurrentPatentAssignee:SUZHOUYUNXUANMEDICINESCIENCETECHNOLOGY-CN104876912,2017,B

[5]CurrentPatentAssignee:EPIZYME,INC.-US2019/83482,2019,A1

[1]Stankyavichyus,A.P.;Terent'ev,P.B.;Bolotin,V.A.;Lashin,V.V.;Rakhimi,I.M.[ChemistryofHeterocyclicCompounds,1988,p.403-409][KhimiyaGeterotsiklicheskikhSoedinenii,1988,vol.24,#4,p.491-498]

[2]Dong,Yan;Li,Kehuang;Xu,Zhixiang;Ma,Haikuo;Zheng,Jiyue;Hu,Zhilin;He,Sudan;Wu,Yiyuan;Sun,Zhijian;Luo,Lusong;Li,Jiajun;Zhang,Hongjian;Zhang,Xiaohu[BioorganicandMedicinalChemistry,2015,vol.23,#21,p.6855-6868]

[3]CurrentPatentAssignee:SUZHOUYUNXUANMEDICINESCIENCETECHNOLOGY-CN104876912,2017,B

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:118933-92-9 Molecular Formula|118933-92-9 MDL|118933-92-9 SMILES|118933-92-9 1-Methyl-1h-indazol-6-ol |Heterocyclic_Building_Blocks